A detailed history of Gamma Investing LLC transactions in Novartis Ag stock. As of the latest transaction made, Gamma Investing LLC holds 5,437 shares of NVS stock, worth $534,728. This represents 0.06% of its overall portfolio holdings.

Number of Shares
5,437
Previous 4,078 33.33%
Holding current value
$534,728
Previous $434 Million 44.05%
% of portfolio
0.06%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$106.13 - $120.89 $144,230 - $164,289
1,359 Added 33.33%
5,437 $625 Million
Q2 2024

Jul 02, 2024

BUY
$92.57 - $107.37 $71,186 - $82,567
769 Added 23.24%
4,078 $434 Million
Q1 2024

Apr 05, 2024

SELL
$95.27 - $108.47 $14,766 - $16,812
-155 Reduced 4.47%
3,309 $320 Million
Q4 2023

Feb 01, 2024

BUY
$92.27 - $101.54 $319,623 - $351,734
3,464 New
3,464 $358 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.